Mar 5, 2026 09:28AM
Feb 19, 2026 08:43AM
Jan 13, 2026 08:05AM
Dec 19, 2025 07:01AM
Dec 10, 2025 08:28AM
Dec 9, 2025 12:48PM
Dec 9, 2025 12:48PM Sidoti Events, LLC's Year-End Virtual Investor Conference
Dec 9, 2025 12:48PM
Dec 9, 2025 12:48PM
Dec 8, 2025 02:54AM
Nov 21, 2025 08:48AM
Nov 20, 2025 08:03AM
Nov 6, 2025 08:08AM
Nov 3, 2025 09:00AM Evaxion adds cancer vaccine candidate EVX-04 to development pipeline
Oct 30, 2025 08:03AM
Oct 29, 2025 04:23PM
Oct 20, 2025 06:57AM
Oct 8, 2025 08:12AM
Sep 26, 2025 06:46AM
Sep 25, 2025 07:01AM
Jul 11, 2025 08:01AM Evaxion converts €3.5 million EIB debt to equity via warrant purchase
Jun 25, 2025 08:01AM
Jun 3, 2025 09:16AM
May 28, 2025 06:56AM
May 27, 2025 04:20PM
May 27, 2025 07:31AM
Apr 28, 2025 08:01AM
Feb 14, 2025 08:03AM Evaxion Biotech (EVAX):Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination
Feb 3, 2025 06:50AM
Jan 30, 2025 08:01AM
Jan 28, 2025 08:15AM
Dec 30, 2024 08:02AM
Dec 17, 2024 08:07AM
Dec 12, 2024 08:04AM
Nov 13, 2024 08:01AM Evaxion Biotech (EVAX) receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing
Nov 12, 2024 08:00AM
Oct 31, 2024 04:28PM
Oct 9, 2024 08:02AM
Oct 3, 2024 08:01AM
Sep 27, 2024 06:52AM
Sep 26, 2024 07:31AM
Sep 20, 2024 06:55AM H.C. Wainwright Reiterates Buy Rating on Evaxion Biotech (EVAX)
Sep 19, 2024 08:01AM
Sep 16, 2024 07:00AM
Sep 9, 2024 08:03AM
Sep 9, 2024 07:07AM
Jul 3, 2024 08:05AM
Jun 26, 2024 07:31AM
Jun 17, 2024 08:45AM Evaxion Biotech (EVAX) Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All